{"id":57828,"date":"2026-04-09T06:06:27","date_gmt":"2026-04-09T06:06:27","guid":{"rendered":"https:\/\/prosfunds.com\/?p=57828"},"modified":"2026-04-09T06:06:29","modified_gmt":"2026-04-09T06:06:29","slug":"mesoblast-limited-meso-discusses-cellular-medicine-platforms-and-innovations-at-rd-day-transcript","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=57828","title":{"rendered":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&#038;D Day Transcript"},"content":{"rendered":"<div>\n<header class=\"flex flex-col items-start justify-between\"><\/header>\n<div class=\"relative mb-18 flex items-start justify-between\" data-test-id=\"author-brief\">\n<div class=\"relative z-0 mr-18 flex\">\n<div class=\"flex shrink-0 items-center justify-center relative size-36 rounded-full\" data-test-id=\"user-pic-wrapper\"><\/div>\n<\/div>\n<p><button data-state-text=\"Following\" aria-label=\"Follow SA Transcripts\" class=\"ihjjQ py-8 px-18 ml-auto print:hidden relative inline-flex items-center justify-center select-none hover:no-underline transition-colors motion-reduce:transition-none border-black bg-black text-white hover:bg-black-70 disabled:border-transparent disabled:bg-black-20 dark:border-black-10 dark:bg-black-10 dark:text-black dark:hover:border-black-30 dark:hover:bg-black-30 dark:disabled:bg-black-30 min-h-36 border text-medium-b px-16 py-1 whitespace-nowrap break-words rounded-8 cursor-pointer\" data-test-id=\"follow-button\" type=\"button\"><span class=\"\"><span aria-hidden=\"true\" class=\"wMAFB relative flex justify-center\" data-state-placeholder=\"Following\"><span class=\"absolute\">Follow<\/span><\/span><\/span><\/button><\/div>\n<div class=\"mb-12\">\n<div aria-label=\"Audio player\" class=\"relative mb-8 mr-8\"><button id=\"sa-audio-player-play-button\" class=\"inline-flex items-center font-bold md:hidden relative inline-flex items-center justify-center select-none hover:no-underline transition-colors motion-reduce:transition-none border-black bg-black text-white hover:bg-black-70 disabled:border-transparent disabled:bg-black-20 dark:border-black-10 dark:bg-black-10 dark:text-black dark:hover:border-black-30 dark:hover:bg-black-30 dark:disabled:bg-black-30 min-h-36 border text-medium-b size-36 p-6 whitespace-nowrap break-words rounded-8 cursor-pointer shrink-0\" data-test-id=\"play-button\" type=\"button\"><span class=\"size-24 m-0 relative flex shrink-0 items-center justify-center [&amp;&gt;svg]:max-h-full [&amp;&gt;svg]:max-w-full [&amp;&gt;svg]:shrink-0 [&amp;&gt;svg]:grow [&amp;&gt;svg]:fill-current\"><span class=\"flex size-16 text-current\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 16 16\" class=\"flex shrink-0 fill-current\" data-test-id=\"play-button-play-svg\"><path fill=\"currentColor\" d=\"M0 16V0l16 8z\"><\/path><\/svg><\/span><\/span><span class=\"sr-only\"><span class=\"font-bold b4Wu7\">Play Earnings Call<\/span><\/span><\/button><button id=\"sa-audio-player-play-button\" class=\"items-center font-bold hidden md:inline-flex relative inline-flex items-center justify-center select-none hover:no-underline transition-colors motion-reduce:transition-none border-black bg-black text-white hover:bg-black-70 disabled:border-transparent disabled:bg-black-20 dark:border-black-10 dark:bg-black-10 dark:text-black dark:hover:border-black-30 dark:hover:bg-black-30 dark:disabled:bg-black-30 min-h-36 border text-medium-b px-16 py-1 whitespace-nowrap break-words rounded-8 cursor-pointer\" data-test-id=\"play-button\" type=\"button\"><span class=\"size-24 mr-8 relative flex shrink-0 items-center justify-center [&amp;&gt;svg]:max-h-full [&amp;&gt;svg]:max-w-full [&amp;&gt;svg]:shrink-0 [&amp;&gt;svg]:grow [&amp;&gt;svg]:fill-current\"><span class=\"flex size-16 text-current\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 16 16\" class=\"flex shrink-0 fill-current\" data-test-id=\"play-button-play-svg\"><path fill=\"currentColor\" d=\"M0 16V0l16 8z\"><\/path><\/svg><\/span><\/span><span class=\"\"><span class=\"font-bold b4Wu7\">Play Earnings Call<\/span><\/span><\/button><\/div>\n<\/div>\n<div class=\"paywall-full-content R6FbO flex sa-text-content sa-media-content sa-table-content sa-content-helpers print:block mb-32\">\n<div class=\"w-0 grow print:w-auto\">\n<div>\n<div class=\"T2G6W\" data-test-id=\"content-container\">\n<div class=\"transcript-headline\">\n<p data-eci=\"true\">Mesoblast Limited (<span class=\"ticker-hover-wrapper\">MESO<\/span>) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026 8:00 AM EDT<\/p>\n<\/div>\n<div class=\"transcript-company-participants\">\n<p class=\"transcript-company-participants-title\"><strong>Company Participants<\/strong><\/p>\n<p><span>Paul Hughes &#8211; Global Head of Corporate Communications &amp; Joint Company Secretary<\/span><br \/><span>Silviu Itescu &#8211; Founder, CEO, MD, Chairman of Scientific Advisory Board &amp; Executive Director <\/span><br \/><span>Marcelo Santoro &#8211; Chief Commercial Officer<\/span><br \/><span>Michael Schuster &#8211; Co-Founder and Head of Pharma Partnering<\/span><br \/><span>Roger Brown<\/span><br \/><span>Kenneth Borow &#8211; Executive<\/span><br \/><span>Eric Rose &#8211; Chief Medical Officer &amp; Executive Director<\/span><br \/><span>Daniel Devine<\/span><br \/><span>Justin Horst &#8211; Head of Manufacturing<\/span><br \/><span>James O\u2019Brien &#8211; Chief Financial Officer<\/span><br \/><span>Michael Schuster<\/span><\/p>\n<\/p><\/div>\n<div class=\"transcript-other-participants\">\n<p class=\"transcript-other-participants-title\"><strong>Conference Call Participants<\/strong><\/p>\n<p><span>Joanne Kurtzberg<\/span><br \/><span>Susan Prockop<\/span><br \/><span>Douglas Beall<\/span><br \/><span>Emerson Perin<\/span><br \/><span>Saad J. Kenderian<\/span><br \/><span>Thaddeus Barney &#8211; Piper Sandler &amp; Co., Research Division<\/span><br \/><span>Thomas Shrader &#8211; BTIG, LLC, Research Division<\/span><br \/><span>Douglas P. Beall<\/span><br \/><span>Michael Okunewitch &#8211; Maxim Group LLC, Research Division<\/span><br \/><span>Edward Tenthoff &#8211; Piper Sandler &amp; Co., Research Division<\/span><\/p>\n<\/p><\/div>\n<div class=\"transcript-conversation\">\n<p class=\"transcript-conversation-title\"><strong>Conversation<\/strong><\/p>\n<div class=\"transcript-section presenter_speech\" seq=\"0\">\n<p class=\"transcript-section-title\"><span class=\"presenter_speech\"><strong>Paul Hughes<\/strong><\/span><br \/><span><i>Global Head of Corporate Communications &amp; Joint Company Secretary<\/i><\/span><\/p>\n<p>Good morning, and welcome, everyone, to Mesoblast&#8217;s inaugural R&amp;D Day. We&#8217;ve got a wonderful morning planned and appreciate you all investing the time to come along and hear the Mesoblast story.<\/p>\n<p>Before we get started, I&#8217;ll just draw your attention to the slide, the forward-looking statement that I&#8217;ve got displayed on the screen. Okay. So the format will be presentations from Mesoblast program heads and our leaders. And they will be followed by a fireside chat with KOLs, and then we&#8217;ll conclude with Q&amp;A. We&#8217;re delighted to have such a distinguished lineup of industry key opinion leaders for you to hear from today, and we&#8217;re very grateful for their time. <\/p>\n<p>And with that, I&#8217;ll now hand over to Silviu, Mesoblast&#8217;s Chief Executive.<\/p>\n<\/p><\/div>\n<div class=\"transcript-section presenter_speech\" seq=\"1\">\n<p class=\"transcript-section-title\"><span class=\"presenter_speech\"><strong>Silviu Itescu<\/strong><\/span><br \/><span><i>Founder, CEO, MD, Chairman of Scientific Advisory Board &amp; Executive Director <\/i><\/span><\/p>\n<p>Good morning, everybody, and thank you for coming. We&#8217;re very excited to have our inaugural R&amp;D Day and it&#8217;s great to have so many friends in the audience. So nice to see<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<aside><\/aside>\n<\/div>\n<\/div>\n<\/div>\n<footer class=\"border-t border-share-separator-thin py-18 sm:py-24 print:hidden paywall-full-content\" data-test-id=\"post-footer\"><\/footer>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4889324-mesoblast-limited-meso-discusses-cellular-medicine-platforms-and-innovations-at-r-and-d-day?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\" rel=\"nofollow\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Follow Play Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026 8:00 AM EDT Company Participants Paul Hughes &#8211; Global Head of Corporate Communications &amp; Joint Company SecretarySilviu Itescu &#8211; Founder, CEO, MD, Chairman of Scientific Advisory Board &amp; Executive Director Marcelo Santoro &#8211; Chief [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3613,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[38],"tags":[],"class_list":{"0":"post-57828","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day Transcript | Prosfunds<\/title>\n<meta name=\"description\" content=\"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=57828\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day Transcript | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=57828\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-09T06:06:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-09T06:06:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=57828#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=57828\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&#038;D Day Transcript\",\"datePublished\":\"2026-04-09T06:06:27+00:00\",\"dateModified\":\"2026-04-09T06:06:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=57828\"},\"wordCount\":364,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=57828#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=57828\",\"url\":\"https:\/\/prosfunds.com\/?p=57828\",\"name\":\"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2026-04-09T06:06:27+00:00\",\"dateModified\":\"2026-04-09T06:06:29+00:00\",\"description\":\"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=57828#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=57828\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=57828#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&#038;D Day Transcript\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript | Prosfunds","description":"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=57828","og_locale":"en_US","og_type":"article","og_title":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript | Prosfunds","og_description":"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026","og_url":"https:\/\/prosfunds.com\/?p=57828","og_site_name":"Prosfunds","article_published_time":"2026-04-09T06:06:27+00:00","article_modified_time":"2026-04-09T06:06:29+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=57828#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=57828"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&#038;D Day Transcript","datePublished":"2026-04-09T06:06:27+00:00","dateModified":"2026-04-09T06:06:29+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=57828"},"wordCount":364,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=57828#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=57828","url":"https:\/\/prosfunds.com\/?p=57828","name":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2026-04-09T06:06:27+00:00","dateModified":"2026-04-09T06:06:29+00:00","description":"FollowPlay Earnings CallPlay Earnings Call Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&amp;D Day April 8, 2026","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=57828#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=57828"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=57828#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&#038;D Day Transcript"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/57828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57828"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/57828\/revisions"}],"predecessor-version":[{"id":57829,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/57828\/revisions\/57829"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/3613"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}